Locations:

Tag: inflammatory bowel diseases (IBD)

July 19, 2022/Digestive/Research

Biologics Before Surgery Not Associated With Postoperative Infections in IBD Patients

Latest research reinforces other recent findings showing minimal risk

June 23, 2022/Digestive/Research

Pouch Surgery and Patient Comorbidities Are Associated with Male Sexual Dysfunction

Study underscores importance of patient education and clinical follow-up

June 7, 2022/Digestive/Research

Adopting a Precision Medicine Approach to Outcome Prediction in Inflammatory Bowel Disease

Renewed funding accelerates Rieder lab discoveries

May 25, 2022/Digestive/Research

Cost Is Not an Impediment to Enoxaparin Prophylaxis for Many Patients after IBD Surgery

Findings have implications for reducing venous thromboembolisms

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

May 20, 2022/Digestive/Research

Preoperative TNFi Exposure is Safe for Majority of Inflammatory Bowel Disease Patients Needing Surgery

Biologics’ use poses nominal postoperative infection risk

July 15, 2021/Digestive/Research

Study Finds Bidirectional Association Between Celiac Disease and IBD

Results of largest medical records-based analysis to date

June 4, 2021/Digestive/GI

Biosimilar Safety and Efficacy Comparable to Biologic Treatment in IBD Patients

Infliximab-abda offers similar benefits at lower costs

May 26, 2021/Digestive/Research

Low-Dose Aspirin for Extended VTE Prophylaxis After IBD Surgery

A cost-effective alternative to enoxaparin?

May 25, 2021/Digestive/Research

Impact of Biologics Use on Bone Loss in Patients with IBD

Results of the largest population-based study to date

Nodular anterior scleritis in a patient with Behcet’s disease

March 15, 2021/Ophthalmology

Recognizing Noninfectious Autoimmune Scleritis

What to look for and when to use immunosuppressive medications

BackPage 2 of 4Next